T-cell signaling and cancer immunotherapy

T 细胞信号转导和癌症免疫治疗

• 批准号: 368725
• 负责人: Rudd Christopher E
• 金额: $ 355.9万
• 依托单位: Centre de recherche de l'Hôpital Maisonneuve-Rosemont (Montral)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2024-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=368725&lang=en
• 关键词: Cancer; Immune Responses; Immunology; Receptors; Signal Transduction; T-Cells

T-cells of the immune system recognize and eliminate foreign pathogens. Over the past decade, it has become clear that the same cells can recognize and kill tumor cells responsible for cancer. T-cells express stimulatory and inhibitory receptors that dete

免疫系统的t细胞识别并清除外来病原体。在过去的十年里，人们已经清楚地认识到，同样的细胞可以识别并杀死导致癌症的肿瘤细胞。t细胞表达刺激和抑制受体